The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Screening for mutations in Colombian metastatic non-small cell lung cancer (NSCLC) patients (ONCOLGroup).
A. F. Cardona
No relevant relationships to disclose
P. L. Ramos
No relevant relationships to disclose
R. Duarte
No relevant relationships to disclose
H. Carranza
No relevant relationships to disclose
C. J. Castro
No relevant relationships to disclose
M. Lema
No relevant relationships to disclose
C. A. Vargas
No relevant relationships to disclose
A. Jimenez
No relevant relationships to disclose
H. A. Becerra
No relevant relationships to disclose
R. Rosell
No relevant relationships to disclose